Why I Plan to Start a Position in $TEM Soon 🧐

$Tempus AI(TEM)$ Precision Medicine Leadership

• Unmatched Data Scale: Tempus AI boasts over 50 petabytes of clinical & molecular data -- an unrivaled foundation in precision medicine.

• Broad Adoption & Impact: Trusted by 50% of top U.S. cancer centers & processing 30K genomic tests monthly at a 98% accuracy rate -- Tempus has supported over 3M patients with personalized care.

• Pharma Reliance: Over 80% of the world’s top 20 pharmaceutical companies depend on Tempus AI for breakthroughs in drug discovery, clinical trials & real-world evidence.

AI-Driven Insights Beyond Oncology

• Broader Applications: Tempus is actively involved in 200+ projects across cardiology & neurology -- significantly expanding its TAM.

• Rare Disease Innovation: Tempus has identified 500+ unique genetic variants -- accelerating diagnoses & treatments for rare conditions.

Market Opportunity

• Expanding Market Opportunities: The global healthcare AI market is projected to grow at a CAGR of 37% through 2030, while the precision medicine market is expected to exceed $100B -- creating significant growth potential for Tempus.

• Strong Revenue Trajectory: Tempus AI is on track to achieve $1B in annual revenue by 2026 -- fueled by its innovative solutions & increasing adoption across the healthcare & pharmaceutical sectors.

I’ve shared the levels where I plan to start a position with my subscribers -- here’s hoping it hits 🤞

Image

AI Companies and Industry DIG

AI is a marathon, not a sprint, it's a mega trend. Please share you Insights or comments on companies or technologies of AI industry.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

14

1

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":395548107346296,"tweetId":"395548107346296","gmtCreate":1737600567777,"gmtModify":1737600601738,"author":{"id":10000000000010928,"idStr":"10000000000010929","authorId":10000000000010928,"authorIdStr":"10000000000010929","name":"ShayBoloor","avatar":"https://community-static.tradeup.com/news/827c3f97d3890eff0091b72bce53d46d","vip":8,"userType":8,"introduction":"Host of @WOLF_Podcasts","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":711,"starInvestorFlag":false},"themes":[{"themeId":"d8920357bb7e4b278997e831493a942a","categoryId":"7cf744760f454845a1870a05ea4e151d","name":"AI Companies and Industry DIG","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":d8920357bb7e4b278997e831493a942a}&rnconfig={\"headerBarHidden\": true}","description":"AI is a marathon, not a sprint, it's a mega trend. Please share you Insights or comments on companies or technologies of AI industry.","image":"https://community-static.tradeup.com/news/4603961061b4e1f67cb838e908cb17bf"}],"images":[{"img":"https://community-static.tradeup.com/news/94667fb8dd1a5c4d0144e8b88916a9bd","width":"680","height":"378"}],"coverImages":[{"img":"https://community-static.tradeup.com/news/94667fb8dd1a5c4d0144e8b88916a9bd","width":"680","height":"378"}],"title":"Why I Plan to Start a Position in $TEM Soon  🧐","html":"<html><head></head><body><p> <a data-mention-id=\"TEM\" class=\"teditor-mention\" data-mention-name=\"Tempus AI\" href=\"https://ttm.financial/S/TEM\">$Tempus AI(TEM)$</a> Precision Medicine Leadership</p><p>• Unmatched Data Scale: Tempus AI boasts over 50 petabytes of clinical &amp; molecular data -- an unrivaled foundation in precision medicine.</p><p>• Broad Adoption &amp; Impact: Trusted by 50% of top U.S. cancer centers &amp; processing 30K genomic tests monthly at a 98% accuracy rate -- Tempus has supported over 3M patients with personalized care.</p><p>• Pharma Reliance: Over 80% of the world’s top 20 pharmaceutical companies depend on Tempus AI for breakthroughs in drug discovery, clinical trials &amp; real-world evidence.</p><p><strong>AI-Driven Insights Beyond Oncology</strong></p><p>• Broader Applications: Tempus is actively involved in 200+ projects across cardiology &amp; neurology -- significantly expanding its TAM. </p><p>• Rare Disease Innovation: Tempus has identified 500+ unique genetic variants -- accelerating diagnoses &amp; treatments for rare conditions.</p><p><strong>Market Opportunity</strong></p><p>• Expanding Market Opportunities: The global healthcare AI market is projected to grow at a CAGR of 37% through 2030, while the precision medicine market is expected to exceed $100B -- creating significant growth potential for Tempus.</p><p>• Strong Revenue Trajectory: Tempus AI is on track to achieve $1B in annual revenue by 2026 -- fueled by its innovative solutions &amp; increasing adoption across the healthcare &amp; pharmaceutical sectors.</p><p>I’ve shared the levels where I plan to start a position with my subscribers -- here’s hoping it hits  🤞</p><p class=\"t-img-caption\"><img alt=\"Image\" title=\"Image\" src=\"https://community-static.tradeup.com/news/94667fb8dd1a5c4d0144e8b88916a9bd\" tg-width=\"680\" tg-height=\"378\"><span>Image</span></p><p></p></body></html>","htmlText":"<html><head></head><body><p> <a data-mention-id=\"TEM\" class=\"teditor-mention\" data-mention-name=\"Tempus AI\" href=\"https://ttm.financial/S/TEM\">$Tempus AI(TEM)$</a> Precision Medicine Leadership</p><p>• Unmatched Data Scale: Tempus AI boasts over 50 petabytes of clinical &amp; molecular data -- an unrivaled foundation in precision medicine.</p><p>• Broad Adoption &amp; Impact: Trusted by 50% of top U.S. cancer centers &amp; processing 30K genomic tests monthly at a 98% accuracy rate -- Tempus has supported over 3M patients with personalized care.</p><p>• Pharma Reliance: Over 80% of the world’s top 20 pharmaceutical companies depend on Tempus AI for breakthroughs in drug discovery, clinical trials &amp; real-world evidence.</p><p><strong>AI-Driven Insights Beyond Oncology</strong></p><p>• Broader Applications: Tempus is actively involved in 200+ projects across cardiology &amp; neurology -- significantly expanding its TAM. </p><p>• Rare Disease Innovation: Tempus has identified 500+ unique genetic variants -- accelerating diagnoses &amp; treatments for rare conditions.</p><p><strong>Market Opportunity</strong></p><p>• Expanding Market Opportunities: The global healthcare AI market is projected to grow at a CAGR of 37% through 2030, while the precision medicine market is expected to exceed $100B -- creating significant growth potential for Tempus.</p><p>• Strong Revenue Trajectory: Tempus AI is on track to achieve $1B in annual revenue by 2026 -- fueled by its innovative solutions &amp; increasing adoption across the healthcare &amp; pharmaceutical sectors.</p><p>I’ve shared the levels where I plan to start a position with my subscribers -- here’s hoping it hits  🤞</p><p class=\"t-img-caption\"><img alt=\"Image\" title=\"Image\" src=\"https://community-static.tradeup.com/news/94667fb8dd1a5c4d0144e8b88916a9bd\" tg-width=\"680\" tg-height=\"378\"><span>Image</span></p><p></p></body></html>","text":"$Tempus AI(TEM)$ Precision Medicine Leadership • Unmatched Data Scale: Tempus AI boasts over 50 petabytes of clinical & molecular data -- an unrivaled foundation in precision medicine. • Broad Adoption & Impact: Trusted by 50% of top U.S. cancer centers & processing 30K genomic tests monthly at a 98% accuracy rate -- Tempus has supported over 3M patients with personalized care. • Pharma Reliance: Over 80% of the world’s top 20 pharmaceutical companies depend on Tempus AI for breakthroughs in drug discovery, clinical trials & real-world evidence. AI-Driven Insights Beyond Oncology • Broader Applications: Tempus is actively involved in 200+ projects across cardiology & neurology -- significantly expanding its TAM. • Rare Disease Innovation: Tempus has identified 500+ unique genetic variants -- accelerating diagnoses & treatments for rare conditions. Market Opportunity • Expanding Market Opportunities: The global healthcare AI market is projected to grow at a CAGR of 37% through 2030, while the precision medicine market is expected to exceed $100B -- creating significant growth potential for Tempus. • Strong Revenue Trajectory: Tempus AI is on track to achieve $1B in annual revenue by 2026 -- fueled by its innovative solutions & increasing adoption across the healthcare & pharmaceutical sectors. I’ve shared the levels where I plan to start a position with my subscribers -- here’s hoping it hits 🤞 Image","highlighted":1,"essential":1,"paper":2,"likeSize":14,"commentSize":0,"repostSize":1,"favoriteSize":0,"link":"https://ttm.financial/post/395548107346296","repostId":0,"isVote":1,"tweetType":1,"viewCount":352,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["TEM"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":true,"length":1203,"optionInvolvedFlag":true,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/395548107346296"}